Ensign Peak Advisors
TENX icon

Ensign Peak Advisors’s Tenax Therapeutics TENX Stock Holding History

Ensign Peak Advisors’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.57M Buy
+176,889
New +$2.26M ﹤0.01% 688

Other funds holding TENX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Ensign Peak Advisors's TENX Position: Q2 2026 in Review

Ensign Peak Advisors opened a new position in Tenax Therapeutics (TENX) in Q2 2026: 176,889 shares worth $2.57M. The stake represents ﹤0.01% of the portfolio and ranks #688 among its holdings.

111 funds tracked by Wall St. Rank hold TENX as of Q2 2026.

  • Ensign Peak Advisors held 176,889 shares of Tenax Therapeutics worth $2.57M as of Q2 2026.
  • Tenax Therapeutics was a new Ensign Peak Advisors position in Q2 2026.
  • Tenax Therapeutics made up ﹤0.01% of Ensign Peak Advisors's portfolio in Q2 2026, its #688 holding.
  • 111 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q2 2026.

Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.